Related Experiment Video
Updated: Jul 17, 2026

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Published on: February 6, 2018
Characterization of monoclonal antibodies to human soluble MD-2 protein
Suganya Viriyakosol1, Paul B McCray, Mark E Ashbaugh
1Veterans Medical Research Foundation, San Diego, California, USA. sviriyak@ucsd.edu
Abstract:
Toll-like receptors (TLRs) are mammalian innate immune recognition receptors that are activated by pathogen associated molecular patterns (PAMPs). TLR4 is the signaling molecule of the lipopolysaccharide (LPS) receptor complex. TLR4 associates with its adapter molecule, MD-2, which is absolutely required for LPS-induced activation of TLR4. MD-2 exists as a cell surface protein in association with TLR4 and as secreted forms consisting of MD-2 monomers and multimers. To facilitate the studies of MD-2 distribution, abundance, and function, we produced monoclonal antibodies (MAbs) to baculovirally expressed soluble MD-2 (sMD-2). Eleven MAbs were characterized by enzyme-linked immunosorbent assay (ELISA) with soluble TLR4/MD-2 complex (sTLR4/MD-2) and sMD-2, Western blotting against sMD-2 monomer and multimers, and inhibition of direct LPS binding to sMD-2. Four MAbs preferentially recognized mainly MD-2 oligomers, not monomers, as judged by Western blotting and ELISA. Anti-MD-2 MAbs useful for indirect immunofluorescent staining of cells expressing TLR4 and MD-2 were identified. One MAb that recognized all forms of MD-2 was used in an ELISA to measure sMD-2 in normal human sera as well as sera from intensive care patients with and without sepsis. Serum levels of sMD-2 were undetectable or very low in normal and in nonsepsis patients but significantly (p < 0.05) increased in sepsis patients. These MAbs should therefore be very useful new tools for studies of MD-2 expression and function in health and disease.
Insights
Researchers developed new monoclonal antibodies (MAbs) to study MD-2, a key molecule in Toll-like receptor 4 (TLR4) activation. These antibodies detected soluble MD-2 (sMD-2) in sepsis patients, showing increased levels in disease.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Toll-like receptors (TLRs) are crucial for innate immunity, recognizing pathogen-associated molecular patterns (PAMPs).
- Toll-like receptor 4 (TLR4) signaling requires the adapter molecule MD-2, which exists in cell-associated and soluble forms.
- Understanding MD-2's distribution and function is vital for studying TLR4-mediated immune responses.
Purpose of the Study:
- To generate and characterize monoclonal antibodies (MAbs) against soluble MD-2 (sMD-2).
- To utilize these MAbs for studying MD-2 expression and its role in health and disease, particularly sepsis.
Main Methods:
- Production of MAbs against baculovirally expressed sMD-2.
- Characterization using ELISA, Western blotting, and inhibition assays for LPS binding.
- Application of a specific MAb in ELISA to quantify sMD-2 levels in human sera.
Main Results:
- Eleven MAbs were generated and characterized, with some showing specificity for MD-2 oligomers.
- MAbs suitable for immunofluorescence staining of TLR4/MD-2 expressing cells were identified.
- Serum sMD-2 levels were significantly elevated in sepsis patients compared to healthy individuals and non-sepsis patients.
Conclusions:
- The developed MAbs are valuable tools for investigating MD-2 expression and function.
- Elevated serum sMD-2 levels are a potential biomarker for sepsis.
- These antibodies will advance research into TLR4-MD-2 complex roles in immunity and disease pathogenesis.
More Related Videos
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
08:58Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques
Published on: July 5, 2018
Related Concept Videos
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.